Is C81.02 a billable ICD-10-CM code?

Yes. C81.02 is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does C81.02 sit in the tabular list?

Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).

C81.02

C81.02 — Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes

Billable / specific codeICD-10-CM

C81.02 is a billable, specific ICD-10-CM code for nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes. It is valid for submission on a claim.

Risk adjustment

C81.02 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 21 Lymphoma and Other Cancers0.671 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

C81.02 is named in 52 Medicare coverage policies — 52 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article

Related codes at this level

Codes that share C81.0. If C81.02 is not quite right, the correct code is usually one of these.

Questions about C81.02

Is C81.02 a billable ICD-10-CM code?: Yes. C81.02 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does C81.02 sit in the tabular list?: Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).